)
Denali Therapeutics (DNLI) investor relations material
Denali Therapeutics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Commercial launch readiness for tividenofusp alfa (DNL310) established ahead of April 2026 FDA decision for Hunter syndrome.
Preliminary Phase 1/2 data for DNL126 in Sanfilippo syndrome type A support accelerated approval plans; global Phase 3 study in planning.
Start-up activities underway for DNL628 (Alzheimer's) and DNL952 (Pompe disease) Phase 1 studies.
Multiple programs advancing in lysosomal storage disorders and neurodegenerative diseases.
$275M synthetic royalty funding and $200M public offering completed in December 2025.
Financial highlights
Net loss was $128.5M for Q4 2025 and $512.5M for FY 2025, compared to $114.8M and $422.8M in 2024.
R&D expenses were $97.9M for Q4 and $418.8M for FY 2025, up $22.4M year-over-year due to higher external costs and manufacturing expansion.
General and administrative expenses rose to $39.5M for Q4 and $136.6M for FY 2025, driven by headcount and launch preparation.
Cash, cash equivalents, and marketable securities totaled $966.2M as of December 31, 2025.
Outlook and guidance
Anticipated FDA decision and commercial launch for tividenofusp alfa in April 2026.
Initial patient data for TAK-594/DNL593 (FTD-GRN) and Phase 2b LUMA study (Parkinson's) expected in 2026.
Four to six additional programs expected to enter the clinic over the next three years.
Next Denali Therapeutics earnings date
Next Denali Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage